Sarah Gheuens
2021
Compensation breakdown
Non-Equity Incentive Plan | $247,501 |
---|---|
Option Awards | $103,524 |
Salary | $437,583 |
Stock Awards | $367,626 |
Other | $13,275 |
Total | $1,169,510 |
Gheuens received $437.6K in salary, accounting for 37% of the total pay in 2021.
Gheuens also received $247.5K in non-equity incentive plan, $103.5K in option awards, $367.6K in stock awards and $13.3K in other compensation.
Rankings
In 2021, Sarah Gheuens' compensation ranked 8,218th out of 12,412 executives tracked by ExecPay. In other words, Gheuens earned more than 33.8% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 8,218 | 34th |
Manufacturing | 3,633 | 34th |
Chemicals And Allied Products | 1,617 | 32nd |
Drugs | 1,437 | 31st |
Pharmaceutical Preparations | 1,067 | 31st |
Pay ratio
Sarah Gheuens' Pay | $1,169,510 |
---|---|
Median Employee's Pay | $315,091 |
Pay Ratio | 4to 1 |
In 2021, the annual total compensation of Sarah Gheuens was $1,169,510.
The annual total compensation of the median employee at Agios Pharmaceuticals was $315,091.
The ratio of Sarah Gheuens' pay to the pay of median employee was therefore 4 to one.
Gheuens' colleagues
We found six more compensation records of executives who worked with Sarah Gheuens at Agios Pharmaceuticals in 2021.
2021
Jacqualyn Fouse
Agios Pharmaceuticals
Chief Executive Officer
2021
Jonathan Biller
Agios Pharmaceuticals
Chief Financial Officer
2021
Bruce Car
Agios Pharmaceuticals
Chief Scientific Officer
2021
Christopher Bowden
Agios Pharmaceuticals
Chief Medical Officer
2021
Darrin Miles
Agios Pharmaceuticals
Former Chief Commercial Officer
2021
Richa Poddar
Agios Pharmaceuticals